JAZZ vs GILD: Which Stock is Better?
Side-by-side comparison of Jazz Pharmaceuticals Plc and Gilead Sciences Inc in 2026
JAZZ
Jazz Pharmaceuticals Plc
$203.42
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | JAZZ | GILD | Winner |
|---|---|---|---|
| Market Cap | $12.52B | $170.84B | GILD |
| P/E Ratio | N/A | 20.27 | GILD |
| EPS (TTM) | $N/A | $6.79 | GILD |
| Revenue Growth | 0.1% | 0.0% | JAZZ |
| Gross Margin | 91.7% | 78.8% | JAZZ |
Analyze JAZZ
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is JAZZ or GILD a better investment?
Comparing JAZZ and GILD: Jazz Pharmaceuticals Plc has a market cap of $12.52B while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between JAZZ and GILD?
JAZZ (Jazz Pharmaceuticals Plc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: JAZZ or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: JAZZ or GILD?
JAZZ has higher revenue growth at 0.1% vs 0.0% for GILD.
Which company is more profitable: JAZZ or GILD?
Jazz Pharmaceuticals Plc (JAZZ) has higher gross margins at 91.7% compared to 78.8% for GILD.
Which is the larger company: JAZZ or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $12.52B for JAZZ.
Should I buy JAZZ or GILD in 2026?
Both JAZZ and GILD have investment merit. JAZZ trades at $203.42 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between JAZZ and GILD stock?
Key differences: Market Cap ($12.52B vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (0.1% vs 0.0%), Gross Margin (91.7% vs 78.8%).